Vaccination Protocols & Guidance

Local Guidance & SOPs:

Vaccine Choice Policy V 1.1

Vaccine requests out of guidance:

• GP letter template -vaccine requests out of guidance

PSDs (Patient Specific Directions for the Administration of COVID-19 Vaccines:

• Use of PSDs for Patients Outside the National Protocol V 1.1
• Primary Care Vaccination Site PSD for Pfizer V 1.0
• Primary Care Vaccination Site PSD for AstraZeneca V 1.0

Competencies for Vaccinating Children:

• 210805 12-15 Children Self Assessment Check List Part A 02.08.25
• 210805 16-17 Children Self Assessment Check List Part A 02.08.21

On Site Clinical Lead Guidance:

• Onsite Clinical Lead Guidance V1.2
• Session Briefing – Vaccinator Consenters V1.2

Information for Consenters:

• Consenters Information PFIZER V 4.1
• Consenters Information AstraZeneca V 4.2
• Moderna Primary Vaccination Course Consenters Information 17.12.21docx
• Consenters’ Information Moderna Booster Vaccination 2021 (1)

COVID Vaccine Trial Participants – Guidance:

Process for Vaccinating COVID Vaccine Trial Participants V 1.0

• Primary Care Vaccination Site PSD for Pfizer V 1.0
• Primary Care Vaccination Site PSD for AstraZeneca V 1.0

Consent Support Information for Responsible Clinicians for Pfizer & AstraZeneca Vaccines:

220628 Latest Vaccination Protocols and Guidance COVID-19 Vaccine – Information for Clinicians (Supporting Patient Assessment and Frequently Asked Questions) V5.14

Allergy Clinic Referral – Letter to Registered Practice Template:

Allergy Clinic form for LVS V 1.0

Specific Vaccination National Protocols:

Pfizer/BioNTech Vaccine:

Pfizer BioNTech National Protocol V 03.00 

AstraZeneca Vaccine:

AstraZeneca National Protocol V 02.00_with cover page April 21

National Guidance & SOPs:

COVID-19 Vaccination Programme FAQs on Second Dose

INCREASED FLEXIBILITY TO OFFER VACCINATION TO COHORTS 3 AND 4 Version 2_22.01.21

C1034 Vaccination Centre Operating Framework 8 January 2021

C1038-COVID-19-Vaccine-Deployment-in-Community-Settings-LVS-SOP-v3.2-14-January-2021

JCVI Guidance – Priority Groups – 6th Jan 2021

Legal mechanisms for administration of the COVID-19 Vaccine

C1039_System letter COVID-19 second dose_11jan21 (002)

Covid-19 Vaccination Scheduling and PHE Delivery and Surveillance Strategy:

• COVID-19 Vacc Scheduling & PHE Delivery_LMC Letter 18.01.21
• COVID-19 Vaccine Surveillance Strategy
• UK COVID-19 Vaccines Delivery Plan Final

PGDs for Pfizer/BionTech & AstraZeneca Vaccines:

C1013-patient-group-direction-summary-for-covid-19-vaccines-6-jan-2021

C0956-PfizerBioNTechCOVID-19PGD-v02.00-updated-5-January-2021 (1)Word Document

C1012-patient-group-direction-for-covid-19-vaccine-astra-zeneca-ChAdOx1-S-6-jan-2021 (2)Word Document

Pfizer Vaccine List of Excipients:

Pfizer Vaccine List of Excipients 210205

Pinnacle Information:

Administration/ Pinnacle NIMS Checking Policy – Pinnacle Process notes V2.1

Pinnacle_Additional Information Questions for PoC Data Capture 26.01.21

Pinnacle Paper Backup Form V 1.1 (Includes Ethnicity Questions)

Patient Information Leaflets:

• Vaccination Guide for Healthcare Workers
• A Guide to your COVID-19 vaccination (Patient Leaflet)
• A Guide to the COVID-19 vaccination for women of childbearing age, pregnant or breastfeeding
• A Guide to the Use of Human and Animal Products in Vaccines